Filed in archive
Treatment
by Gloria Gamat on February 23, 2006
Following trials to prove that it prevents the disease, the world's first cervical cancer vaccine, called Gardasil, is expected to go on sale in New Zealand in October for females aged 9 to 24. In the near future, men may also be offered injections of the cervical cancer vaccine to protect themselves from other diseases and prevent them from infecting their sexual partners.
The company which will supply Gardasil in New Zealand, CSL, says the vaccine development and clinical trials focused first on women due to the greater burden from cervical cancer than HPV-linked cancers in men.
Large trials were under way with men and the results were expected within three years, product manager Joanna Hayward-Slattery said.
Earlier trials showed the vaccine increased antibody levels against its four target HPV types - two linked to cancer and two to genital warts - in both men and women.
According to CSL, the vaccine is most useful if given before any sexual activity begins - prior to exposure to HPV - but it may be useful later too.
Source: The New Zealand HeraldPhoto Credit: [Physician's Research Network]
Permalink: cervical vaccine, maybe beneficial to men
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/16029
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for cervical vaccine, maybe beneficial to men:
|
Rating: 8.67 out of 3 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
